Titanium(IV) Complexes Bearing [O-NX] (X ) O, S, Se)
Organometallics, Vol. 25, No. 13, 2006 3265
13C NMR (75 MHz, CDCl3): δ 163.9 (CHdN), 151.6, 147.4, 136.3,
135.6, 135.0, 133.2, 132.2, 131.1, 130.4, 129.1, 129.0, 128.9, 128.8,
127.3, 125.4, 119.7, 35.4, 34.7, 31.2, 29.7. IR (KBr) ν: 1581, 1479,
1442, 1236, 1202, 1175, 865. Anal. Calcd for C27H30NOSCl3Ti:
C, 56.81; H, 5.30; N, 2.45. Found: C, 57.67; H, 5.73; N, 2.05.
[N-(3,5-Di-tert-butylsalicylidene)-2-(2,6-dimethylphenysulfanyl)-
anilinato] Ti(IV)Cl3 (5k). The same procedure as that for the
preparation of 5a was used. KH (0.065 g, 1.6 mmol), L11 (0.72 3
g, 1.6 mmol), and TiCl4 (0.31 g, 1.6 mmol) were used. Yield: 0.62
1
g (64%). H NMR (300 MHz, CD2Cl2): δ 8.91 (s, 1H, CHdN);
7.83 (d, J ) 2.4 Hz, 1H, Ar-H), 7.68-7.44 (m, 4H, Ar-H), 7.26-
7.09 (m, 4H, Ar-H), 2.29 (s, 6H, CH3); 1.53 (s, 9H, t-Bu); 1.41
(s, 9H, t-Bu). 13C NMR (75 MHz, CD2Cl2): δ 163.8 (CHdN),
161.4, 154.3, 154.1, 150.4, 137.7, 136.6, 135.0, 134.6, 132.9, 132.8,
132.1, 129.8, 129.1, 127.1, 119.4, 116.9, 37.2, 36.6, 32.7, 31.4,
20.6. IR (KBr) ν: 1582, 1536, 1472, 1374, 1276, 1246, 1179, 872.
Anal. Calcd for C29H34NOSCl3Ti: C, 58.14; H, 5.68; N, 2.33.
Found: C, 57.84; H, 5.43; N, 2.09.
[N-(3,5-Di-tert-butylsalicylidene)-2-(4-trifluoromethyl-
phenylsulfanyl)anilinato]Ti(IV)Cl3 (5f). The same procedure as
that for the preparation of 5a was used. KH (0.040 g, 1 mmol), L6
(0.485 g, 1 mmol), and TiCl4 (0.23 g, 1.2 mmol) were used. Yield:
0.510 g (78%). 1H NMR (300 MHz, CDCl3): δ 8.90 (s, 1H,
CHdN); 7.77 (d, J ) 2.1 Hz, 1H, Ar-H), 7.69-7.54 (m, 6H, Ar-
H), 7.40 (d, J ) 5.1 Hz, 2H, Ar-H), 7.23 (m, 1H, Ar-H), 1.52 (s,
9H, t-Bu); 1.34 (s, 9H, t-Bu). 19F NMR (282.3 MHz, CDCl3): δ
63.2. IR (KBr) ν: 1607, 1556, 1327, 1246, 1169, 1062, 1012, 876.
Anal. Calcd for C28H29NOF3SCl3Ti: C, 52.64; H, 4.58; N, 2.19.
Found: C, 52.95; H, 4.96; N, 1.90.
[N-(3,5-Di-tert-butylsalicylidene)-2-(2,6-di-isopropylphenysul-
fanyl)anilinato]Ti(IV)Cl3 (5l). The same procedure as that for the
preparation of 5a was used. KH (0.161 g, 4 mmol), L12 (2.00 g,
4 mmol), and TiCl4 (0.76 g, 4 mmol) were used. Yield: 1.83 g
(70%). 1H NMR (300 MHz, CDCl3): δ 8.54 (s, 1H, CHdN); 7.74
(d, J ) 1.8 Hz, 1H, Ar-H), 7.70 (d, J ) 7.5 Hz, 1H, Ar-H),
7.49-7.03 (m, 6H, Ar-H), 6.47 (d, J ) 8.1 Hz, 1H, Ar-H)), 3.57
(hapta, 2H, J ) 6.9 Hz, CH(CH3)2); 1.62 (s, 9H, t-Bu); 1.35 (s,
9H, t-Bu); 1.15 (d, J ) 14.7 Hz, 12H, CH(CH3)2). 13C NMR (75
MHz, CDCl3): δ 170.4 (CHdN), 160.3, 154.0, 147.2, 137.5, 132.2,
130.7, 130.1, 129.0, 128.2, 127.6, 126.8, 126.5, 125.9, 125.5, 125.2,
124.4, 35.4, 34.7, 31.9, 31.2, 29.8, 25.4, 24.1. IR (KBr) ν: 1598,
1560, 1549, 1462, 1362, 1271, 1179, 1002, 875. Anal. Calcd for
C33H42NOSCl3Ti: C, 60.51; H, 6.46; N, 2.14. Found: C, 59.38;
H, 7.04; N, 1.58.
[N-(3,5-Di-tert-butylsalicylidene)-2-(3-chlorophenysulfanyl)-
anilinato]Ti(IV)Cl3 (5g). The same procedure as that for the
preparation of 5a was used. KH (0.140 g, 3.5 mmol), L7 (1.581 g,
3.5 mmol), and TiCl4 (0.67 g, 3.5 mmol) were used. Yield: 1.60
1
g (76%). H NMR (300 MHz, CDCl3): δ 8.89 (s, 1H, CHdN);
7.75-7.53 (m, 6H, Ar-H), 7.29-7.15 (m, 4H, Ar-H), 1.52 (s,
9H, t-Bu); 1.37 (s, 9H, t-Bu). 13C NMR (75 MHz, CDCl3): δ 164.1
(CHdN), 151.7, 147.6, 136.7, 136.3, 135.9, 135.0, 133.4, 132.6,
131.3, 130.6, 130.2, 129.1, 129.0, 128.2, 128.1, 127.3,127.2, 124.3,
119.9, 35.4, 34.8, 31.2, 29.7. IR (KBr) ν: 1585, 1542, 1473, 1364,
1245, 1184, 870. Anal. Calcd for C27H29NOSCl4Ti: C, 53.58; H,
4.83; N, 2.33. Found: C, 54.36; H, 5.22; N, 2.11.
[N-(3,5-Di-tert-butylsalicylidene)-2-(4-methoxylphenysulfanyl)-
anilinato]Ti(IV)Cl3 (5h). The same procedure as that for the
preparation of 5a was used. KH (0.140 g, 3.5 mmol), L8 (1.56 g,
3.5 mmol), and TiCl4 (0.67 g, 3.5 mmol) were used. Yield: 1.53
[N-(3,5-Di-tert-butylsalicylidene)-2-phenylselanylanilinato]-
Ti(IV)Cl3 (5m). The same procedure as that for the preparation of
5a was used. KH (0.100 g, 2.5 mmol), L13 (1.15 g, 2.5 mmol),
and TiCl4 (0.475 g, 2.5 mmol) were used. Yield: 1.01 g (65%).
1H NMR (300 MHz, CDCl3): δ 8.79 (s, 1H, CHdN); 7.74-7.26
(m, 11H, Ar-H), 1.51 (s, 9H, t-Bu); 1.35 (s, 9H, t-Bu). 13C NMR
(75 MHz, CD2Cl3): δ 167.2 (CHdN), 163.0, 155.1, 149.6, 138.4,
137.8, 135.0, 134.9, 134.0, 133.1, 132.2, 132.0, 131.3, 130.9, 129.4,
126.1, 122.8, 37.1. 36.6, 32.8, 31.3. IR (KBr) ν: 1645, 1606, 1557,
1472, 1249, 853. Anal. Calcd for C27H30NOSeCl3Ti: C, 52.50; H,
4.90; N, 2.27. Found: C, 53.21; H, 5.37; N, 2.01.
1
g (71%). H NMR (300 MHz, CDCl3): δ 8.90 (s, 1H, CHdN);
7.74 (s, 1H, Ar-H), 7.60-7.54 (m, 4H, Ar-H), 7.46-7.33 (m,
3H, Ar-H), 6.88(d, J ) 5.7 Hz, 2H, Ar-H), 3.79 (s, 3H, OCH3);
1.52 (s, 9H, t-Bu); 1.36 (s, 9H, t-Bu). 13C NMR (75 MHz, CDCl3):
δ 163.9 (CHdN), 161.3, 160.4, 151.1, 147.4, 136.4, 134.7, 133.1,
131.7, 131.3, 131.1, 130.3, 127.3, 125.4, 119.5, 114.7, 55.4, 35.4,
34.8, 31.2, 29.7. IR (KBr) ν: 1614, 1593, 1494, 1463, 1388, 1250,
1180, 1026, 878. Anal. Calcd for C28H29NO2S Cl3Ti: C, 55.95; H,
5.33; N, 2.33. Found: C, 56.45; H, 5.41; N, 2.24.
[N-(3-tert-Butylsalicylidene)-2-phenylsulfanylanilinato]Ti(IV)-
Cl3 (5n). The same procedure as that for the preparation of 5a was
used. KH (0.100 g, 3 mmol), L14 (1.083 g, 3 mmol), and TiCl4
[N-(3,5-Di-tert-butylsalicylidene)-2-(3-methoxylphenysulfanyl)-
anilinato]Ti(IV)Cl3 (5i). The same procedure as that for the
preparation of 5a was used. KH (1.56 g, 3.5 mmol), L9 (1.56 g,
3.5 mmol), and TiCl4 (0.67 g, 3.5 mmol) were used. Yield: 1.78
1
(0.57 g, 3 mmol) were used. Yield: 1.1 g (71%). H NMR (300
MHz, CD2Cl2): δ 8.91 (s, 1H, CHdN); 7.76-7.64 (m, 6H, Ar-
H), 7.40-7.24 (m, 6H, Ar-H), 1.50 (s, 9H, t-Bu). 13C NMR (75
MHz, CD2Cl2): δ 165.7 (CHdN), 164.9, 153.5, 138.6, 137.5, 137.4,
137.0, 136.6, 134.3, 132.6, 130.9, 130.8, 129.5, 127.1, 126.6, 121.7,
37.0, 31.2. IR (KBr) ν: 1582, 1545, 1468, 1376, 1254. Anal. Calcd
for C23H22NOSCl3Ti: C, 53.67; H, 4.31; N, 2.72. Found: C, 54.19;
H, 4.37; N, 2.37.
1
g (85%). H NMR (300 MHz, CDCl3): δ 8.85 (s, 1H, CHdN);
7.73 (s, 1H, Ar-H), 7.64-7.54 (m, 5H, Ar-H), 7.26-7.22 (m,
1H, Ar-H), 6.90-6.83 (m, 3H, Ar-H), 3.73 (s, 3H, OCH3); 1.52
(s, 9H, t-Bu); 1.35 (s, 9H, t-Bu). 13C NMR (75 MHz, CDCl3): δ
163.9 (CHdN), 161.5, 159.7, 151.5, 147.4, 136.1, 136.0, 135.7,
133.1, 132.3, 131.3, 130.3, 129.9, 127.3, 125.4, 121.2, 119.7, 114.6,
55.4, 35.3, 34.7, 31.2, 29.7. IR (KBr) ν: 1591, 1541, 1476, 1362,
1286, 1246, 1185, 1043, 858. Anal. Calcd for C28H29NO2SCl3Ti:
C, 55.95; H, 5.33; N, 2.33. Found: C, 56.52; H, 5.44; N, 2.24.
Polymerization Procedure. To a 100 mL flame-dried flask
was added 50 mL of freshly distilled toluene (and the re-
quired amount of 1-hexene in the case of copolymerization) at the
desired polymerization temperature. After 10 min, MMAO was
added. The resulting mixture was stirred for a further 5 min, and
the precursor catalyst solution in toluene was injected via a
syringe. The polymerization was carried out for the desired
time and then quenched with concentrated HCl in ethanol (100 mL,
HCl/ethanol, 1:20, v/v). The precipitated polymer was collected,
washed with ethanol, and then dried overnight in a vacuum oven
at 50 °C.
[N-(3,5-Di-tert-butylsalicylidene)-2-(2,6-dichlorophenysulfanyl)-
anilinato]Ti(IV)Cl3 (5j). The same procedure as that for the
preparation of 5a was used. KH (0.075 g, 1.9 mmol), L10 (0.911
g, 1.9 mmol), and TiCl4 (0.38 g, 2 mmol) were used. Yield: 0.887
1
g (73%). H NMR (300 MHz, CD2Cl2): δ 8.85 (s, 1H, CHdN);
7.83 (d, J ) 2.4 Hz, 1H, Ar-H), 7.66-7.27 (m, 8H, Ar-H), 1.54
(s, 9H, t-Bu); 1.40 (s, 9H, t-Bu). 13C NMR (75 MHz, CDCl3): δ
163.9 (CHdN), 158.3, 145.9, 141.9, 140.5, 137.0, 131.4, 130.6,
128.9, 128.3, 127.0, 126.9, 126.4, 126.0, 124.3, 118.3, 118.1, 35.1,
34.1, 31.4, 29.4. IR (KBr) ν: 1645, 1597, 1540, 1473, 1423, 1270,
1183, 852. Anal. Calcd for C27H28NOSCl5Ti: C, 52.80; H, 4.47;
N, 2.24. Found: C, 52.26; H, 4.93; N, 1.70.
X-ray Structure Determination. Data collections for com-
plexes 5a, 5e, 5g, 5i, and 5n were performed at 20 °C on a Bruker
SMART diffractometer with graphite-monochromated Mo KR